Ignite Creation Date:
2025-12-24 @ 11:59 AM
Ignite Modification Date:
2025-12-30 @ 1:44 PM
Study NCT ID:
NCT02094261
Status:
COMPLETED
Last Update Posted:
2024-11-06
First Post:
2014-03-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II AZD9291 Open Label Study in NSCLC After Previous EGFR TKI Therapy in EGFR and T790M Mutation Positive Tumours
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-05-20
Start Date Type:
ACTUAL
Primary Completion Date:
2015-05-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-07
Completion Date Type:
ACTUAL
First Submit Date:
2014-03-17
First Submit QC Date:
None
Study First Post Date:
2014-03-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-04-28
Results First Submit QC Date:
None
Results First Post Date:
2016-06-07
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-05
Last Update Post Date:
2024-11-06
Last Update Post Date Type:
ACTUAL